Higher risk of heart disease found in babies of Sjögren’s mothers
Newborns of mothers with primary Sjögren’s disease may be at a higher risk of developing heart conditions, a study in China says.| Sjogren's Syndrome News
Efgartigimod is entering a Phase 3 clinical trial after data from a proof-of-concept Phase 2 trial showed it outperformed a placebo at easing symptoms and signs of primary Sjögren’s disease, the treatment’s developer said. Argenx shared the data at the European Congress of Rheumatology (EULAR) 2025, held June 11-14 in Barcelona, in a presentation, “Treatment of […] The post Efgartigimod in Phase 3 testing for Sjogren’s as data show promise appeared first on Sjogren's Syndrome News.| Sjogren's Syndrome News – The Web's Daily Resource for Sjogren's Syndrome News
Newborns of mothers with primary Sjögren’s disease may be at a higher risk of developing heart conditions, a study in China says.| Sjogren's Syndrome News
Mimicking the activity of a microRNA molecule eased inflammation and scarring in Sjögren’s rats, pointing to a potential therapeutic target.| Sjogren's Syndrome News
Andrea Lobo is a science writer for Sjogren's Syndrome News with a PhD in cell biology/neurosciences. She covers the latest news and information on a variety of Sjogren's topics.| Sjogren's Syndrome News
Lindsey Shapiro is a science writer for Sjogren's Syndrome News with a PhD in neuroscience. She covers the latest news and information on a variety of Sjogren's syndrome topics.| Sjogren's Syndrome News
Marisa Wexler is a senior science writer for Sjogren's Syndrome News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of Sjogren's syndrome topics.| Sjogren's Syndrome News
Category archive page for News.| Sjogren's Syndrome News
